Actions
Pages
Subscribe for newsletter
Stories
Therapeutic Plasma Exchange (TPE), traditionally a treatment for autoimmune disorders, has emerged as a new technique in longevity science. By cleansing the blood of aging-related cells and replenishing it with clean, individualized plasma-like fluids, this process supports the body and brain's ability to combat degeneration.
TPE aligns with the focus on personalized medicine and regenerative therapies for combating aging diseases like Alzheimer's at the cellular level. With an aging global population, TPE's potential in reducing healthcare burdens and enhancing life quality gains relevance.
TPE’s principle of 'spring cleaning' the blood is a radical way to treat aging. Specific figures are still pending but ongoing research and trials will reveal more results of TPE’s efficacy.
Story
Rocket Lab has secured a $515 million contract to construct and manage 18 small satellites for a U.S. government agency, as revealed in an SEC regulatory filing. The customer is likely the Space Development Agency (SDA), an organization under the U.S. Space Force, working on the Proliferated Warfighter Space Architecture, a network of military satellites in low Earth orbit.
The small satellite (smallsat) sector, valued at $3.23 billion, is projected to reach $5.88 billion by 2030 due to innovative technologies and rising application demands. This trend highlights a shift towards versatile, cost-effective space technologies. Rocket Lab's contract supports strategic defense and communication advancements, underlining the growing commercial use of space by the military.
Rocket Lab's ongoing projects, the Neutron rocket and the Photon satellites, showcase the company's forward trajectory, expanding operations and competing in the larger payload market. The satellite launches are planned for 2026 and 2027.
The broader context is the U.S. making continued efforts to preserve their edge in the strategic space domain. The incorporation of advanced communication technologies in satellites such as using UHF and S-band frequencies for beyond line-of-sight connectivity highlights this.
Story
Centralization of research and data has contributed to the lack of trust in scientific institutions and research, leading to a replicability crisis and wasting of taxpayer funds. The emergence of Web3 and blockchain technology provides a pathway for open access to data and manuscripts to ensure data integrity, scalability, flexibility, and data sovereignty while eliminating data silos. This model will create incentives for scientists to share research, data, and code openly, leading to progress and verifiable discoveries with the potential to improve human lives.
Open science practices, including open access to scientific manuscripts, are crucial to decentralize science within the FAIR principles (findable, accessible, interoperable, reusable).
VitaDAO is a decentralized biotech company dedicated to longevity science research. They communicate openly on platforms like Discord and Discourse and token holders can vote on strategic decisions.
Open science raises questions about the balance between open accessibility and the need to protect sensitive data. However FAIR principles don't mandate blanket data accessibility and decentralized tools like IPFS allow controlled access. Funding agencies are also encouraging data sharing. It seems the adoption of open science practices is becoming essential for progress in scientific research.
Story
Innovators
Scroll
Open
Close